The Great Britain is witnessing a growing surge in interest surrounding copyright substances. Beyond the well-established use of psilocybin and LSD, scientists and explorers are increasingly delving into less-charted territories, particularly copyright and the relatively new cannabinoid, CBG. This burgeoning movement encompasses therapeutic researc